Patents by Inventor Tobias Hintermann
Tobias Hintermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11209142Abstract: A daylight illumination system for integration into a building or larger vehicle comprises a translucent facade element (800) containing a glass sheet and a light redirection element (302 or 708), and a light transport channel (801) for guiding light about horizontally into an interior of the building, the light transport channel comprising one opening attached to the interior side of said facade element and at least one opening towards the interior of the building, characterised in that the light redirection element (302 or 708) is formed as a structured polymer film or sheet attached to a glass sheet of the facade element (800) and is configured for changing the direction of incident light into the about horizontal light transport channel.Type: GrantFiled: June 10, 2020Date of Patent: December 28, 2021Assignee: Skynative UGInventors: Tobias Hintermann, Patrice Bujard, Andre Kostro, Adrian Von Muehlenen, Cristobal Garrido Segura
-
Publication number: 20200378572Abstract: A daylight illumination system for integration into a building or larger vehicle comprises a translucent facade element (800) containing a glass sheet and a light redirection element (302 or 708), and a light transport channel (801) for guiding light about horizontally into an interior of the building, the light transport channel comprising one opening attached to the interior side of said facade element and at least one opening towards the interior of the building, characterised in that the light redirection element (302 or 708) is formed as a structured polymer film or sheet attached to a glass sheet of the facade element (800) and is configured for changing the direction of incident light into the about horizontal light transport channel.Type: ApplicationFiled: June 10, 2020Publication date: December 3, 2020Inventors: Tobias HINTERMANN, Patrice BUJARD, Andre KOSTRO, Adrian VON MUEHLENEN, Cristobal GARRIDO SEGURA
-
Patent number: 10794557Abstract: A daylighting panel for integration into a building or larger vehicle comprises a translucent facade element (800) containing a glass sheet and a light transport channel (801) for guiding light about horizontally into an interior of the building, the light transport channel comprising one opening attached to the interior side of said facade element and at least one opening towards the interior of the building equipped with a luminaire (807), characterised in that the inner walls including the rear end are covered by a reflecting layer (808).Type: GrantFiled: November 2, 2017Date of Patent: October 6, 2020Assignee: BASF SEInventors: Cristobal Garrido Segura, Tobias Hintermann, Andre Kostro, Tatjana Vetter
-
Patent number: 10718479Abstract: A daylight illumination system for integration into a building or larger vehicle comprises a translucent facade element (800) containing a glass sheet and a light redirection element (302 or 708), and a light transport channel (801) for guiding light about horizontally into an interior of the building, the light transport channel comprising one opening attached to the interior side of said facade element and at least one opening towards the interior of the building, characterised in that the light redirection element (302 or 708) is formed as a structured polymer film or sheet attached to a glass sheet of the facade element (800) and is configured for changing the direction of incident light into the about horizontal light transport channel.Type: GrantFiled: November 2, 2017Date of Patent: July 21, 2020Assignee: BASF SEInventors: Tobias Hintermann, Patrice Bujard, Andre Kostro, Adrian Von Muehlenen, Cristobal Garrido Segura
-
Publication number: 20190305165Abstract: Described herein is a structured reflector for a photovoltaic module, where the structured reflector provides improved light conversion and efficiency, and a photovoltaic module comprising the reflector. In a photovoltaic module, a reflector sheet is arranged below photovoltaic cells, with a microstructured surface of the reflector sheet facing towards the cells. The microstructured surface comprises three-dimensional reflectors in the form of cones, whose apexes direct towards an upper surface of the photovoltaic module and whose aperture ranges from 100° to 140°.Type: ApplicationFiled: May 9, 2017Publication date: October 3, 2019Inventors: Patrice Bujard, Vjosa Statovci, Jan-Bernd Kues, Adrian von Muehlenen, Tobias Hintermann, Jan Gebers, Sven Olle Krabbenborg
-
Publication number: 20190285238Abstract: A daylighting panel for integration into a building or larger vehicle comprises a translucent facade element (800) containing a glass sheet and a light transport channel (801) for guiding light about horizontally into an interior of the building, the light transport channel comprising one opening attached to the interior side of said facade element and at least one opening towards the interior of the building equipped with a luminaire (807), characterised in that the inner walls including the rear end are covered by a reflecting layer (808).Type: ApplicationFiled: November 2, 2017Publication date: September 19, 2019Inventors: Cristobal GIRRADO SEGURA, Tobias HINTERMANN, Andre KOSTRO, Tatjana VETTER
-
Publication number: 20190285237Abstract: A daylight illumination system for integration into a building or larger vehicle comprises a translucent facade element (800) containing a glass sheet and a light redirection element (302 or 708), and a light transport channel (801) for guiding light about horizontally into an interior of the building, the light transport channel comprising one opening attached to the interior side of said facade element and at least one opening towards the interior of the building, characterised in that the light redirection element (302 or 708) is formed as a structured polymer film or sheet attached to a glass sheet of the facade element (800) and is configured for changing the direction of incident light into the about horizontal light transport channel.Type: ApplicationFiled: November 2, 2017Publication date: September 19, 2019Inventors: TOBIAS HINTERMANN, Patrice BUJARD, Andre KOSTRO, Adrian VON MUEEHLENEN, Cristobal GARRIDO SEGURA
-
Patent number: 10207261Abstract: The present invention provides a photolatent Ti-chelate catalyst formulation, comprising (i) at least one compound of the formula (I) wherein R1 is C1-C20alkyl or C2-C20alkyl which is interrupted by one or more non-consecutive O-atoms; Y is formula (II) or optionally substituted phenyl; Y1 is formula (III) or optionally substituted phenyl; Y2 is formula (IV) or optionally substituted phenyl; Y3 is formula (V) or optionally substituted phenyl; R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 independently of each other are hydrogen, halogen, optionally substituted C1-C20alkyl, or R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 independently of each other are optionally substituted C6-C14aryl, provided that only one of R2, R3, R4 is hydrogen and only one of R5, R6, R7 is hydrogen and only one of R8, R9, R10 is hydrogen and only one of R11, R12, R13 is hydrogen; and (ii) at least one chelate ligand compound of the formula IIa, IIb or IIc, wherein Y? is formula (VI) or formula (VII); Y?1 is formula (VIType: GrantFiled: September 9, 2010Date of Patent: February 19, 2019Assignee: BASF SEInventors: Tobias Hintermann, Didier Bauer, Antoine Carroy, Caroline Lordelot, Rachel Kohli Steck
-
Patent number: 10105355Abstract: The present invention primarily relates to multi-component crystals comprising a compound of formula 1 and a second compound selected from the group consisting of co-crystal formers and solvents. The invention is further related to pharmaceutical compositions comprising such multi-component crystals. Furthermore, the invention relates to processes for preparing said multi-component crystals. The invention also relates to several aspects of using said multi-component crystals or pharmaceutical compositions to treat a disease.Type: GrantFiled: August 3, 2015Date of Patent: October 23, 2018Assignee: BASF SEInventors: Martin Viertelhaus, Tiziana Chiodo, Beate Salvador, Marcus Vossen, Andreas Hafner, Tobias Hintermann, Walter Weishaar, Rolf Hellmann
-
Publication number: 20180230140Abstract: The present invention primarily relates to multicomponent crystals comprising a compound of formula 1 and a second compound selected from the group consisting of menthol and vanillin. The invention is further related to pharmaceutical compositions comprising such multicomponent crystals. Furthermore, the invention relates to processes for preparing said multicomponent crystals. The invention also relates to several aspects of using said multicomponent crystals or pharmaceutical compositions to treat a disease.Type: ApplicationFiled: June 24, 2015Publication date: August 16, 2018Applicant: BASF SEInventors: Martin VIERTELHAUS, Tiziana CHIODO, Beate SALVADOR, Marcus VOSSEN, Andreas HAFNER, Tobias HINTERMANN, Martin SZELAGIEWICZ, Fritz BLATTER
-
Patent number: 10045998Abstract: Combinations of (3?)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate (Abiraterone acetate) with acidic substances such as citric acid, ascorbic acid, methyl-4-hydroxy benzoate, saccharin, vanillic acid, adipic acid, maleic acid, malic acid, tartaric acid are useful as pharmaceutical preparations and show improved properties such as aqueous solubility and dissolution kinetics, especially in the form of cocrystals or their combination with a suitable acid.Type: GrantFiled: December 9, 2014Date of Patent: August 14, 2018Assignee: BASF SEInventors: Tiziana Chiodo, Beate Salvador, Marcus Vossen, Andreas Hafner, Tobias Hintermann, Martin Szelagiewicz, Fritz Blatter, Martin Viertelhaus, Walter Weishaar
-
Publication number: 20180105719Abstract: A titanium-oxo-chelate catalyst formulation, comprising: (i) at least one compound of the formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 independently of each other are for example hydrogen, halogen, C1-C20alkyl, C6-C14aryl which is unsubstituted or substituted; or R1, R2 and R3 and/or R4, R5 and R6 and/or R7, R8 and R9 and/or R10, R11 and R12 together with the C-atom to which they are attached each form a C6-C14aryl group which is unsubstituted or substituted; or R1 and R2 and/or R4 and R5 and/or R7 and R8 and/or R10 and R11 together with the C-atom to which they are attached form a 5- to 7-membered carbocyclic ring; at least one chelate ligand compound of the formula (IIa), (IIb) or (IIc), wherein R1, R2, R3, R4, R5 and R6 are defined as above for formula (I), is suitable as a photolatent catalyst formulation for polymerizing compounds, which are capable to crosslink in the presence of a Lewis acid.Type: ApplicationFiled: October 20, 2017Publication date: April 19, 2018Inventors: Tobias Hintermann, Antoine Carroy, Caroline Lordelot, Didier Bauer, Rachel Kohli Steck, Marc Faller
-
Patent number: 9884857Abstract: The present invention primarily relates to salts of Dasatinib, wherein the salts are in amorphous form. The salts described herein preferably comprise a cation of a compound of formula 1 and an anion of a second compound selected from the group consisting of glutaric acid, nicotinic acid and saccharin. The invention is further related to pharmaceutical compositions comprising such a salt. Furthermore, the invention relates to processes for preparing said salts. The invention also relates to several aspects of using said salt or pharmaceutical composition to treat a disease.Type: GrantFiled: July 22, 2014Date of Patent: February 6, 2018Assignee: BASF SEInventors: Andreas Hafner, Fritz Blatter, Martin Szelagiewicz, Bernd Siebenhaar, Tiziana Chiodo, Tobias Hintermann, Beate Salvador, Marcus Vossen
-
Patent number: 9809727Abstract: A titanium-oxo-chelate catalyst formulation, comprising: (i) at least one compound of the formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 independently of each other are for example hydrogen, halogen, C1-C20alkyl, C6-C14aryl which is unsubstituted or substituted; or R1, R2 and R3 and/or R4, R5 and R6 and/or R7, R8 and R9 and/or R10, R11 and R12 together with the C-atom to which they are attached each form a C6-C14aryl group which is unsubstituted or substituted; or R1 and R2 and/or R4 and R5 and/or R7 and R8 and/or R10 and R11 together with the C-atom to which they are attached form a 5- to 7-membered carbocyclic ring; at least one chelate ligand compound of the formula (IIa), (IIb) or (IIc), wherein R1, R2, R3, R4, R5 and R6 are defined as above for formula (I), is suitable as photolatent catalyst formulation for polymerizing compounds, which are capable to crosslink in the presence of a Lewis acid.Type: GrantFiled: April 2, 2012Date of Patent: November 7, 2017Assignee: BASF SEInventors: Tobias Hintermann, Antoine Carroy, Caroline Lordelot, Didier Bauer, Rachel Kohli Steck, Marc Faller
-
Publication number: 20170216266Abstract: The present invention primarily relates to multi-component crystals comprising a compound of formula 1 and a second compound selected from the group consisting of co-crystal formers and solvents. The invention is further related to pharmaceutical compositions comprising such multi-component crystals. Furthermore, the invention relates to processes for preparing said multi-component crystals. The invention also relates to several aspects of using said multi-component crystals or pharmaceutical compositions to treat a disease.Type: ApplicationFiled: August 3, 2015Publication date: August 3, 2017Inventors: MARTIN VIERTELHAUS, Tiziana CHIODO, Beate SALVADOR, Marcus VOSSEN, Andreas HAFNER, Tobias HINTERMANN, Walter WEISHAAR, Rolf HELLMANN
-
Patent number: 9567317Abstract: The present invention relates to crystalline materials comprising nilotinib and a carboxylic acid, carboxylic acid ester, carboxylic acid amide or sulfonic acid as a co-crystal former, and to pharmaceutical compositions comprising said materials. The invention also relates to processes for preparing said crystalline materials and to methods of using said crystalline materials to treat a disease condition in which tyrosine kinase inhibition is beneficial.Type: GrantFiled: October 16, 2013Date of Patent: February 14, 2017Assignee: BASF SEInventors: Tiziana Chiodo, Andreas Hafner, Tobias Hintermann, Beate Salvador, Martin Szelagiewicz, Fritz Blatter, Eva Roedel, Marcus Vossen
-
Patent number: 9556164Abstract: The present invention primarily relates to molecular crystalline substances, preferably salts of Dasatinib in crystalline form, comprising a compound of formula 1, preferably a cation of a compound of formula 1, and a second compound selected from the group consisting of glutaric acid, nicotinic acid and saccharin, preferably an anion thereof. The invention is further related to pharmaceutical compositions comprising such a substance. Furthermore, the invention relates to processes for preparing said substances. The invention also relates to several aspects of using said substances or pharmaceutical compositions to treat a disease.Type: GrantFiled: July 22, 2014Date of Patent: January 31, 2017Assignee: BASF SEInventors: Andreas Hafner, Fritz Blatter, Martin Szelagiewicz, Bernd Siebenhaar, Tiziana Chiodo, Tobias Hintermann, Beate Salvador, Marcus Vossen
-
Patent number: 9527743Abstract: The present invention relates to a process for preparing a graphene nanoribbon, which comprises: (a) providing at least one aromatic monomer compound which is selected from at least one polycyclic aromatic monomer compound, at least one oligo phenylene aromatic monomer compound, or combinations thereof, on a solid substrate, (b) polymerization of the aromatic monomer compound so as to form at least one polymer on the surface of the solid substrate, (c) at least partially cyclodehydrogenating the one or more polymers of step (b), wherein at least step (b) is carried out at a total pressure p(total) of at least 1×10?9 mbar; and a partial oxygen pressure p(O2) and partial water pressure p(H2O) which satisfy the following relation: p(O2)×p(H20)<3×10?14 mbar2.Type: GrantFiled: September 4, 2013Date of Patent: December 27, 2016Assignees: BASF SE, EMPA—Eidgenössische Materialprüfungs-und ForschungsanstaltInventors: Tobias Hintermann, Roman Fasel, Pascal Ruffieux, Jinming Cai, Juan Ramon Sanchez Valencia
-
Publication number: 20160303143Abstract: Combinations of (3?)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate (Abiraterone acetate) with acidic substances such as citric acid, ascorbic acid, methyl-4-hydroxy benzoate, saccharin, vanillic acid, adipic acid, maleic acid, malic acid, tartaric acidare useful as pharmaceutical preparations and show improved properties such as aqueous solubility and dissolution kinetics, especially in the form of cocrystals or their combination with a suitable acid.Type: ApplicationFiled: December 9, 2014Publication date: October 20, 2016Applicant: BASF SEInventors: Tiziana CHIODO, Beate SALVADOR, Marcus VOSSEN, Andreas HAFNER, Tobias HINTERMANN, Martin SZELAGIEWICZ, Fritz BLATTER, Martin VIERTELHAUS, Walter WEISHAAR
-
Publication number: 20160207776Abstract: In a process for purifying graphene nanoribbons, a composition comprising graphene nanoribbons GNR1 and at least one contaminant is brought into contact with a liquid medium that includes a dispersant. The graphene nanoribbons GNR1 are dispersed in the liquid medium so as to obtain a liquid dispersion of the graphene nanoribbons GNR1. The liquid dispersion of the graphene nanoribbons GNR1 is subjected to a separation treatment so as to at least partly remove the at least one contaminant, thereby obtaining a liquid dispersion of purified graphene nanoribbons GNR1.Type: ApplicationFiled: August 25, 2014Publication date: July 21, 2016Inventors: Tobias Hintermann, Matthias Georg Schwab, Kitty Chih-Pei Cha, Thomas Weitz, Ansgar Schäfer, Imke Britta Müller